OPG and Nordion employees at Darlington’s recently refurbished Unit 1, which has been modified to produce cobalt-60 isotopes. (Photo: OPG)
Ontario Power Generation in Canada announced that Unit 1 of its Darlington nuclear power plant, which has returned to service from refurbishment, is now producing the medical isotope cobalt-60. During refurbishment activities, OPG made modifications to the unit to allow it to produce Co-60, which is used to sterilize 30 percent of the world’s single-use medical devices, such as syringes, gloves, and implants.
Panelists for the session, from left, panel moderator Catherine Prat, Westinghouse Electric Company; Riaz Bandali, president of Nordion; Ben Goodrich, a director at TerraPower Isotopes; Ross Radel, chief technology officer at SHINE Technologies; Harsh Desai, chief commercialization officer at Zeno Power; and Alyse Huffman, a professional staff member for the Senate Committee on Energy and Natural Resources. (Photo: ANS)
“What can the atom do for you, other than produce electricity from nuclear reactors?” That was the question asked and answered during an ANS Annual Conference special plenary session on June 18, introduced by ANS President Ken Petersen and organized by the ANS Young Members Group. An expert panel discussed radioisotopes and their supply chains in the context of cancer treatment, product sterilization, power for remote applications, and used nuclear fuel recycling.
Bruce Power and Nordion will increase Co-60 production at the Bruce nuclear power plant in Ontario. (Photo: Bruce Power)
Bruce Power, the utility in Ontario, Canada, and health-care company Nordion announced that they are working to increase the production of cobalt-60 to meet increasing world market demands. The companies said they will increase the amount of Co-60 Bruce Power is able to produce in its reactors “by innovating a new adjuster component configuration.”
